These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 7923571)
1. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital. Tamano S; Merlino GT; Ward JM Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571 [TBL] [Abstract][Full Text] [Related]
2. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver. Moser GJ; Wolf DC; Goldsworthy TL Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259 [TBL] [Abstract][Full Text] [Related]
3. Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice. Diwan BA; Rice JM; Ohshima M; Ward JM Carcinogenesis; 1986 Feb; 7(2):215-20. PubMed ID: 3948311 [TBL] [Abstract][Full Text] [Related]
4. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice. Takagi H; Sharp R; Takayama H; Anver MR; Ward JM; Merlino G Cancer Res; 1993 Sep; 53(18):4329-36. PubMed ID: 8364928 [TBL] [Abstract][Full Text] [Related]
5. Cell proliferation and regulation of negative growth factors in mouse liver foci. Moser GJ; Wolf DC; Harden R; Standeven AM; Mills J; Jirtle RL; Goldsworthy TL Carcinogenesis; 1996 Sep; 17(9):1835-40. PubMed ID: 8824503 [TBL] [Abstract][Full Text] [Related]
6. Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGF-alpha transgenic mice. Puatanachokchai R; Kakuni M; Wanibuchi H; Kinoshita A; Kang JS; Salim EI; Morimura K; Tamano S; Merlino GT; Fukushima S Asian Pac J Cancer Prev; 2006; 7(2):274-8. PubMed ID: 16839222 [TBL] [Abstract][Full Text] [Related]
7. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice. Russell WE; Kaufmann WK; Sitaric S; Luetteke NC; Lee DC Mol Carcinog; 1996 Mar; 15(3):183-9. PubMed ID: 8597531 [TBL] [Abstract][Full Text] [Related]
8. Effect of alpha-tocopherol on hepatocarcinogenesis in transforming growth factor-alpha (TGF-alpha) transgenic mice treated with diethylnitrosamine. Kakizaki S; Takagi H; Fukusato T; Toyoda M; Horiguchi N; Sato K; Takayama H; Nagamine T; Mori M Int J Vitam Nutr Res; 2001 Sep; 71(5):261-7. PubMed ID: 11725690 [TBL] [Abstract][Full Text] [Related]
9. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Ward JM; Rice JM; Creasia D; Lynch P; Riggs C Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148 [TBL] [Abstract][Full Text] [Related]
10. Lack of effect of phenobarbital on hepatocellular carcinogenesis initiated by N-nitrosodiethylamine or methylazoxymethanol acetate in male Syrian golden hamsters. Diwan BA; Ward JM; Anderson LM; Hagiwara A; Rice JM Toxicol Appl Pharmacol; 1986 Nov; 86(2):298-307. PubMed ID: 3787627 [TBL] [Abstract][Full Text] [Related]
11. TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion. Miller RT; Cattley RC; Marsman DS; Lyght O; Popp JA Carcinogenesis; 1995 Jan; 16(1):77-82. PubMed ID: 7530605 [TBL] [Abstract][Full Text] [Related]
12. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice. Sanders S; Thorgeirsson SS Mol Carcinog; 2000 Jul; 28(3):168-73. PubMed ID: 10942533 [TBL] [Abstract][Full Text] [Related]
13. Androgen dependency of hepatocarcinogenesis in TGFalpha transgenic mice. Matsumoto T; Takagi H; Mori M Liver; 2000 Jun; 20(3):228-33. PubMed ID: 10902973 [TBL] [Abstract][Full Text] [Related]
14. Possible tumor development from double positive foci for TGF-alpha and GST-P observed in early stages on rat hepatocarcinogenesis. Kitano M; Wada J; Ariki Y; Kato M; Wanibuchi H; Morimura K; Hidaka T; Hosoe K; Fukushima S Cancer Sci; 2006 Jun; 97(6):478-83. PubMed ID: 16734725 [TBL] [Abstract][Full Text] [Related]
15. Anti-carcinogenic action of phenobarbital given simultaneously with diethylnitrosamine in the rat. Barbason H; Mormont C; Massart S; Bouzahzah B Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1073-8. PubMed ID: 3780814 [TBL] [Abstract][Full Text] [Related]
16. Inhibition by phenobarbital and lack of effect of amobarbital on the development of liver tumors induced by N-nitrosodiethylamine in juvenile B6C3F1 mice. Diwan BA; Rice JM; Ward JM; Ohshima M; Lynch PH Cancer Lett; 1984 Jun; 23(2):223-34. PubMed ID: 6744246 [TBL] [Abstract][Full Text] [Related]
17. Sodium phenobarbital-enhanced mutation frequency in the liver DNA of lacZ transgenic mice treated with diethylnitrosamine. Okada N; Honda A; Kawabata M; Yajima N Mutagenesis; 1997 May; 12(3):179-84. PubMed ID: 9175645 [TBL] [Abstract][Full Text] [Related]
18. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital. Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta receptors type I, II and III in phenobarbital-promoted rat liver tumors. Reisenbichler H; Chari RS; Boyer IJ; Jirtle RL Carcinogenesis; 1994 Dec; 15(12):2763-7. PubMed ID: 8001232 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of the paradoxical, inhibitory effect of phenobarbital on hepatocarcinogenesis initiated in infant B6C3F1 mice with diethylnitrosamine. Lee GH; Ooasa T; Osanai M Cancer Res; 1998 Apr; 58(8):1665-9. PubMed ID: 9563480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]